Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro

被引:85
作者
Visser, CC
Stevanovic, S
Voorwinden, LH
Gaillard, PJ
Crommelin, DJA
Danhof, M
de Boer, AG
机构
[1] Leiden Univ, LACDR, Div Pharmacol, NL-2300 RA Leiden, Netherlands
[2] Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
关键词
blood-brain barrier; horseradish peroxidase; clathrin-mediated endocytosis; drug targeting and delivery; deferoxamine mesylate;
D O I
10.1080/10611860410001701706
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recently, we have shown that transferrin (Tf) is actively endocytosed by the Tf R on primary cultured bovine brain capillary endothelial cells (BCEC). The objective of this investigation is to determine whether the Tf R can facilitate endocytosis of a (protein) model drug, using Tf as a targeting vector. Secondly, the mechanism of endocytosis was investigated. Horseradish peroxidase (HRP, 40 kDa) was chosen as a model drug, since it normally does not cross the blood-brain barrier (BBB) and its concentration in biological media can be easily quantified. Tf-HRP conjugates (1:1) are actively and specifically endocytosed by BCEC in vitro in a concentration and time-dependent manner. At an applied concentration of 3 mug/ml, association (a combination of binding and endocytosis) of Tf-HRP reached equilibrium at a concentration of 2 ng/mg cell protein after 1 h of incubation at 37degreesC. This was approximately 3-fold higher compared to binding at 4degreesC (0.6 ng/mg cell protein). Association of Tf-HRP was compared to BSA-HRP. After 2 h of incubation at 37degreesC association levels were 5.2 and 2.5 ng/mg cell protein, for Tf-HRP and BSA-HRP, respectively. Under those conditions, association of Tf-HRP could be inhibited to approximately 30% of total association by an excess of non-conjugated Tf, but not with BSA, while association of BSA-HRP could be inhibited by both proteins. Furthermore, by using specific inhibitors of endocytotic processes, it was shown that association of Tf-HRP is via clathrin-coated vesicles. Association of Tf-HRP is inhibited by phenylarsine oxide (an inhibitor of clathrin-mediated endocytosis) to 0.4 ng/mg cell protein, but not by indomethacin, which inhibits formation of caveolae. Finally, following iron scavenging by deferoxamine mesylate (DFO, resulting in a higher Tf R expression) a 5-fold increase in association of Tf-HRP to 15.8 ng/mg cell protein was observed. In conclusion, the Tf R is potentially suitable for targeting of a (protein) cargo to the BBB and to facilitate its endocytosis by the BCEC.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 19 条
[1]  
BANKS WA, 1994, J NEUROCHEM, V62, P2404
[2]   Delivery of peptides and proteins through the blood-brain barrier (Reprinted from Advanced Drug Delivery Reviews, vol 10, pg 205-245, 1993) [J].
Bickel, U ;
Yoshikawa, T ;
Pardridge, WM .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :247-279
[3]   The role of drug transporters at the blood-brain barrier [J].
de Boer, AG ;
van der Sandt, ICJ ;
Gaillard, PJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 :629-656
[4]   A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier [J].
Dehouck, B ;
Fenart, L ;
Dehouck, MP ;
Pierce, A ;
Torpier, G ;
Cecchelli, R .
JOURNAL OF CELL BIOLOGY, 1997, 138 (04) :877-889
[5]  
DEVRIES HE, 1993, J NEUROCHEM, V61, P1813
[6]   HIGH-DENSITY-LIPOPROTEIN AND CEREBRAL ENDOTHELIAL-CELLS IN-VITRO - INTERACTIONS AND TRANSPORT [J].
DEVRIES, HE ;
BREEDVELD, B ;
KUIPER, J ;
DEBOER, AG ;
VANBERKEL, TJC ;
BREIMER, DD .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (02) :271-273
[7]  
Fukushima Hisashi, 2001, Methods in Cell Science, V23, P211, DOI 10.1023/A:1016399822589
[8]   Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes [J].
Gaillard, PJ ;
Voorwinden, LH ;
Nielsen, JL ;
Ivanov, A ;
Atsumi, R ;
Engman, H ;
Ringbom, C ;
de Boer, AG ;
Breimer, DD .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 12 (03) :215-222
[9]   Caveolae: An alternative membrane transport compartment [J].
Gumbleton, M ;
Abulrob, ANG ;
Campbell, L .
PHARMACEUTICAL RESEARCH, 2000, 17 (09) :1035-1048
[10]   Transferrin/transferrin receptor-mediated drug delivery [J].
Li, HY ;
Qian, ZM .
MEDICINAL RESEARCH REVIEWS, 2002, 22 (03) :225-250